Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and clinical significance of LTA4H in esophageal squamous cell carcinoma.

Journal of toxicology and environmental health. Part A·2026
Same author

IL-7R-Enriched Extracellular Vesicles From the Thymus Drive Colitis via Promoting Neutrophil Extracellular Trap Formation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

[Frontiers in direct compression technology for traditional Chinese medicine powder: integration of excipient modification, particle design, and continuous manufacturing].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same author

Glycine induces MafG to regulate glutathione metabolism, inhibit chondrocyte ferroptosis, and upregulate plectin to improve osteoarthritis.

Cellular signalling·2026
Same author

Mesoporous polydopamine nanoplatform enhances IL-2 immunotherapy for hepatocellular carcinoma via mild photothermal therapy and lactate regulation.

Asian journal of pharmaceutical sciences·2026

Related Experiment Video

Updated: Jun 26, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

[rAAV/BA46-transfected dendritic cells can induce specific cellular immunity].

Chang-xuan You1, Jin Su, Wang-jun Liao

  • 1Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. ycx6026@yahoo.com

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|December 31, 2008
PubMed
Summary

This study demonstrates that transfecting breast cancer BA46 gene into dendritic cells (DCs) using adeno-associated virus (AAV) effectively induces specific cellular immunity. This approach shows promise for developing novel breast cancer immunotherapies.

More Related Videos

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

Related Experiment Videos

Last Updated: Jun 26, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

Area of Science:

  • Immunology
  • Oncology
  • Gene Therapy

Context:

  • Dendritic cells (DCs) are crucial for initiating immune responses.
  • Breast cancer immunotherapy aims to harness the immune system to fight cancer.
  • Gene transfer into DCs offers a potential strategy for enhancing anti-tumor immunity.

Purpose:

  • To assess the feasibility of using adeno-associated virus (AAV) to deliver the breast cancer BA46 gene into dendritic cells (DCs).
  • To determine if this gene transfer can induce specific cellular immunity against breast cancer.
  • To provide an experimental basis for genetically modified cell-based breast cancer immunotherapy.

Summary:

  • Mononuclear cells were differentiated into DCs and transfected with the BA46 gene using rAAV/BA46/Neo virus.
  • Mature DCs were co-cultured with T cells to induce cytotoxic T lymphocytes (CTLs).
  • Transfected DCs stimulated T cell proliferation and induced CTLs expressing CD8, CD69, and IFN-gamma, with specific cytotoxicity against BA46-positive breast cancer cells.

Impact:

  • Successful BA46 gene transfer into DCs was achieved.
  • The modified DCs effectively stimulated T lymphocyte proliferation and induced antigen-specific CTLs.
  • This research supports the development of genetically modified cell-based immunotherapies for breast cancer.